Skip to main content
Top
Published in:

Open Access 01-12-2024 | COVID-19 | Debate

Canada needs a national COVID-19 inquiry now

Authors: David Fisman, Jillian Horton, Matthew Oliver, Mark Ungrin, Joseph Vipond, Julia M. Wright, Dick Zoutman

Published in: BMC Medicine | Issue 1/2024

Login to get access

Abstract

Background

We are now in the fifth year of an ongoing pandemic, and Canada continues to experience significant surges of COVID-19 infections. In addition to the acute impacts of deaths and hospitalizations, there is growing awareness of an accumulation of organ damage and disability which is building a “health debt” that will affect Canadians for decades to come. Calls in 2023 for an inquiry into the handling of the COVID-19 pandemic went unheeded, despite relevant precedent. Canada urgently needs a comprehensive review of its successes and failures to chart a better response in the near- and long-term.

Main body

While Canada fared better than many comparators in the early years of the COVID-19 pandemic, it is clearly still in a public health crisis. Infections are not only affecting Canadians’ daily lives but also eroding healthcare capacity. Post-COVID condition is having accumulating and profound individual, social, and economic consequences.
An inquiry is needed to understand the current evidence underlying policy choices, identify a better course of action on various fronts, and build resilience. More must be done to reduce transmission, including a serious public education campaign to better inform Canadians about COVID and effective mitigations, especially the benefits of respirator masks. We need a national standard for indoor air quality to make indoor public spaces safer, particularly schools. Data collection must be more robust, especially to understand and mitigate the disproportionate impacts on under-served communities and high-risk populations. General confidence in public health must be rebuilt, with a focus on communication and transparency. In particular, the wide variation in provincial policies has sown mistrust: evidence-based policy should be consistent. Finally, Canada’s early success in vaccination has collapsed, and this development needs a careful post-mortem.

Conclusions

A complete investigation of Canada’s response to the pandemic is not yet possible because that response is still ongoing and, while we have learned much, there remain areas of dispute and uncertainty. However, an inquiry is needed to conduct a rapid assessment of the current evidence and policies and provide recommendations on how to improve in 2025 and beyond as well as guidance for future pandemics.
Literature
8.
go back to reference National Academies of Sciences, Engineering, and Medicine. Long-term health effects of COVID-19: disability and function following SARS-CoV-2 infection. Washington, DC: The National Academies Press, 2024. https://doi.org/10.17226/27756. National Academies of Sciences, Engineering, and Medicine. Long-term health effects of COVID-19: disability and function following SARS-CoV-2 infection. Washington, DC: The National Academies Press, 2024. https://​doi.​org/​10.​17226/​27756.
11.
go back to reference Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al. Systematic review of the prevalence of long COVID. Open Forum Infect Dis. 2023;10(7):ofad233. Epub 20230503. https://doi.org/10.1093/ofid/ofad233. PubMed PMID: 37404951; PubMed Central PMCID: PMCPMC10316694. Woodrow M, Carey C, Ziauddeen N, Thomas R, Akrami A, Lutje V, et al. Systematic review of the prevalence of long COVID. Open Forum Infect Dis. 2023;10(7):ofad233. Epub 20230503. https://​doi.​org/​10.​1093/​ofid/​ofad233. PubMed PMID: 37404951; PubMed Central PMCID: PMCPMC10316694.
18.
go back to reference Greenhalgh T, Jimenez JL, Prather KA, Tufekci Z, Fisman D, Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397(10285):1603–5. Epub 2021/04/19. https://doi.org/10.1016/S0140-6736(21)00869-2. PubMed PMID: 33865497; PubMed Central PMCID: PMCPMC8049599. Greenhalgh T, Jimenez JL, Prather KA, Tufekci Z, Fisman D, Schooley R. Ten scientific reasons in support of airborne transmission of SARS-CoV-2. Lancet. 2021;397(10285):1603–5. Epub 2021/04/19. https://​doi.​org/​10.​1016/​S0140-6736(21)00869-2. PubMed PMID: 33865497; PubMed Central PMCID: PMCPMC8049599.
25.
go back to reference Tseng YJ, Olson KL, Bloch D, Mandl KD. Smart thermometer-based participatory surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic. JAMA Netw Open. 2023;6(6):e2316190. Epub 20230601. https://doi.org/10.1001/jamanetworkopen.2023.16190. PubMed PMID: 37261828; PubMed Central PMCID: PMCPMC10236238. Tseng YJ, Olson KL, Bloch D, Mandl KD. Smart thermometer-based participatory surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic. JAMA Netw Open. 2023;6(6):e2316190. Epub 20230601. https://​doi.​org/​10.​1001/​jamanetworkopen.​2023.​16190. PubMed PMID: 37261828; PubMed Central PMCID: PMCPMC10236238.
26.
go back to reference Funk A, Florin TA, Kuppermann N, Finkelstein Y, Kazakoff A, Baldovsky M, et al. Household transmission dynamics of asymptomatic SARS-CoV-2–infected children: a multinational, controlled case-ascertained prospective study, Clin Infect Dis 2024;ciae069. https://doi.org/10.1093/cid/ciae069. Funk A, Florin TA, Kuppermann N, Finkelstein Y, Kazakoff A, Baldovsky M, et al. Household transmission dynamics of asymptomatic SARS-CoV-2–infected children: a multinational, controlled case-ascertained prospective study, Clin Infect Dis 2024;ciae069. https://​doi.​org/​10.​1093/​cid/​ciae069.
31.
go back to reference Pickering K, Galappaththi EK, Ford JD, Singh C, Zavaleta-Cortijo C, Hyams K, et al. Indigenous peoples and the COVID-19 pandemic: a systematic scoping review. Environ Res Lett. 2023;18(3):033001. Epub 20230213. https://doi.org/10.1088/1748-9326/acb804. PubMed PMID: 36798651; PubMed Central PMCID: PMCPMC9923364. Pickering K, Galappaththi EK, Ford JD, Singh C, Zavaleta-Cortijo C, Hyams K, et al. Indigenous peoples and the COVID-19 pandemic: a systematic scoping review. Environ Res Lett. 2023;18(3):033001. Epub 20230213. https://​doi.​org/​10.​1088/​1748-9326/​acb804. PubMed PMID: 36798651; PubMed Central PMCID: PMCPMC9923364.
33.
go back to reference Bosworth ML, Ayoubkhani D, Nafilyan V, Foubert J, Glickman M, Davey C, et al. Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study. Lancet Public Health. 2021;6(11):e817-e25. Epub 20211007. https://doi.org/10.1016/S2468-2667(21)00206-1. PubMed PMID: 34626547; PubMed Central PMCID: PMCPMC8494502. Bosworth ML, Ayoubkhani D, Nafilyan V, Foubert J, Glickman M, Davey C, et al. Deaths involving COVID-19 by self-reported disability status during the first two waves of the COVID-19 pandemic in England: a retrospective, population-based cohort study. Lancet Public Health. 2021;6(11):e817-e25. Epub 20211007. https://​doi.​org/​10.​1016/​S2468-2667(21)00206-1. PubMed PMID: 34626547; PubMed Central PMCID: PMCPMC8494502.
34.
39.
go back to reference Link-Gelles R, Ciesla AA, Mak J, Miller JD, Silk BJ, Lambrou AS, Paden CR, Shirk P, Britton A, Smith ZR, Fleming-Dutra KE. Early estimates of updated 2023–2024 (Monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults - increasing community access to testing program, United States, September 2023-January 2024. MMWR 2024 Feb 1;73(4):77–83. https://doi.org/10.15585/mmwr.mm7304a2. Link-Gelles R, Ciesla AA, Mak J, Miller JD, Silk BJ, Lambrou AS, Paden CR, Shirk P, Britton A, Smith ZR, Fleming-Dutra KE. Early estimates of updated 2023–2024 (Monovalent XBB.1.5) COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection attributable to co-circulating Omicron variants among immunocompetent adults - increasing community access to testing program, United States, September 2023-January 2024. MMWR 2024 Feb 1;73(4):77–83. https://​doi.​org/​10.​15585/​mmwr.​mm7304a2.
40.
go back to reference Mercadé-Besora N, Li X, Kolde R, Trinh NT, Sanchez-Santos MT, Man WY, Roel E, Reyes C, Delmestri A, Nordeng HME, Uusküla A, Duarte-Salles T, Prats C, Prieto-Alhambra D, Jödicke AM, Català M. The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications. Heart. 2024 Mar 12:heartjnl-2023–323483. https://doi.org/10.1136/heartjnl-2023-323483. Epub ahead of print. Mercadé-Besora N, Li X, Kolde R, Trinh NT, Sanchez-Santos MT, Man WY, Roel E, Reyes C, Delmestri A, Nordeng HME, Uusküla A, Duarte-Salles T, Prats C, Prieto-Alhambra D, Jödicke AM, Català M. The role of COVID-19 vaccines in preventing post-COVID-19 thromboembolic and cardiovascular complications. Heart. 2024 Mar 12:heartjnl-2023–323483. https://​doi.​org/​10.​1136/​heartjnl-2023-323483. Epub ahead of print.
Metadata
Title
Canada needs a national COVID-19 inquiry now
Authors
David Fisman
Jillian Horton
Matthew Oliver
Mark Ungrin
Joseph Vipond
Julia M. Wright
Dick Zoutman
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2024
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-024-03756-7

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more